Sramek BioDynamics

What Sramek BioDynamics does

Sramek BioDynamics Inc. is a privately held medical device company that develops and commercializes cardiovascular monitoring systems based on proprietary Thoracic Electrical Bioimpedance (TEB) technology. The company sells two core products: the HOTMAN System, an FDA 510(k)-cleared and CE-marked hospital-grade hemodynamic and oxygen transport management device that provides non-invasive continuous cardiac output measurement along with clinical decision support for hypertension and ICU management; and Cardiax, a home-use cardiovascular monitor with an open API for integration with consumer health bands. The underlying technology, originally developed by founder Dr. B. Bo Sramek beginning in 1980, relies on Sramek's patented equation for stroke volume calculation and is supported by over 50 clinical studies validating its accuracy against invasive cardiac output measurement.

The company's business model combines hardware sales of medical devices with associated professional services for hemodynamic management. It pursues a dual go-to-market: enterprise field sales to hospitals and medical centers for the HOTMAN System, and direct-to-consumer sales for Cardiax paired with health band integrations. Manufacturing is outsourced to Radius, a subsidiary of Fortune 200 company JABIL, under a partnership established in 2018. Sramek BioDynamics operates from offices in Los Angeles (manufacturing and marketing), Hong Kong (investment relations), and Guangzhou (operations), and is actively recruiting distributors globally with particular emphasis on the China market. The company was re-incorporated in 2018 when CEO Toney KM Lam acquired the underlying IP, and no institutional funding rounds or revenue figures are publicly disclosed.

The company faces a key leadership transition risk following the death of founder Dr. Bo Sramek in 2019, while the original technology lineage traces back to BoMed Medical Manufacturing Ltd. (NASDAQ-BOMD, later CardioDynamics International Corporation/NASDAQ-CDIC), providing the technology with decades of clinical validation but also a long commercialization history under prior entities.

Name

Sramek BioDynamics

Legal name

Sramek BioDynamics Inc.

Website

https://sramekbiodynamics.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Sramek BioDynamics Inc. develops and markets non-invasive cardiovascular monitoring devices based on proprietary Thoracic Electrical Bioimpedance (TEB) technology, serving hospitals with the HOTMAN System and home consumers with the Cardiax device for cardiac output and hemodynamic measurement.

Ownership category

akta.pro rank

Product category

Cardiovascular Monitoring Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)

akta.pro secondary industries

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Hypertension & Ambulatory Blood Pressure Care (HLAKABAH)

Keywords

• Non-invasive cardiac monitoring
• Hemodynamic management
• Thoracic electrical bioimpedance
• Cardiovascular medical devices
• Stroke volume measurement

Headquarters

HQ city

Irvine

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Device Sales: Sale of HOTMAN System to hospitals and medical centers for hemodynamic monitoring. Sale of Cardiax device to consumers for home cardiovascular monitoring.
2. Healthcare Services: Providing hemodynamic management services including hypertension treatment outcomes, CHF management, chemotherapy hemodynamic support, hemodialysis management, and preoperative/ICU hemodynamic management.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Sramek BioDynamics develops and sells non-invasive cardiovascular monitoring medical devices built on proprietary Thoracic Electrical Bioimpedance (TEB) technology. Its two core product lines are the HOTMAN System, an FDA 510(k)-cleared and CE-marked hospital hemodynamic and oxygen transport monitoring system with built-in clinical decision support, and Cardiax, a home-use real-time cardiovascular monitor that pairs with health bands (SPO2, ECG, Blood Pressure, Sleep Motion) via an open API interface. The company also provides accompanying hemodynamic management services covering hypertension treatment outcomes, CHF management, chemotherapy hemodynamic support, hemodialysis management, and preoperative/ICU hemodynamic management.

Product overview

Sramek BioDynamics offers a portfolio of medical devices built on proprietary Thoracic Electrical Bioimpedance (TEBCO) technology for hemodynamic monitoring. The product line comprises two distinct systems: (1) HOTMAN System — a hospital-grade FDA 510(k) cleared and CE approved device that provides comprehensive hemodynamic and oxygen transport monitoring with clinical decision support for achieving normohemodynamic state; and (2) Cardiax — a home-use cardiovascular monitoring device with an open API interface for integration with health bands (SPO2, ECG, Blood Pressure, Sleep Motion). Both products leverage the same underlying TEB technology originally developed by Dr. B. Bo Sramek and validated in over 50 clinical studies.

Differentiator

Problem solved

Functional benefit

Brands

• Cardiax: A real-time cardiovascular monitor with hemodynamics data designed for home use to reduce the risk of heart stroke. It is a cost-effective device with cutting-edge technology to precisely predict and manage cardiovascular risk for patients, especially senior citizens. It pairs with health bands via open API interface to collect health data including SPO2, ECG, Blood Pressure, and Sleep Motion.
• HOTMAN System

Products and services

• HOTMAN System (Hemodynamic and Oxygen Transport Monitoring & Management System) FDA 510(k)-cleared and CE-marked registered medical device for non-invasive measurement of blood flow with oxygen and collection of complete hemodynamic data. It identifies causes of abnormal hemodynamic states and provides clinical recommendations on cardioactive and vasoactive agents to help reach the therapeutic goal (normohemodynamic state). Used by hospitals, checkup centers, and healthcare centers.
• Cardiax - Smart Cardiovascular Analysis Device Real-time cardiovascular monitoring device with hemodynamics data designed for home use to reduce risk of heart stroke, especially for senior citizens. Pairs with consumer health bands (SPO2, ECG, Blood Pressure, Sleep Motion) via an open API interface and provides cost-effective, real-time analysis to predict and manage cardiovascular risk.
• Hemodynamic Management Services Professional hemodynamic management services built on the Sramek hemodynamic and oxygen transport management methodology, supporting hypertension treatment, CHF management, chemotherapy hemodynamic support, hemodialysis management, and preoperative/ICU hemodynamic management for hospitals and clinics using the HOTMAN System.

Quantifiable outcome

• Hypertension therapy outcomes can increase from less than 35% to over 90% using HOTMAN system
• +2 more outcomes

Named customers3 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core and minor.

• JABIL (Radius subsidiary)coreOEM/ Whitelabel/ Licensing Partner · 1 March 2018Sramek BioDynamics partnered with Radius, a subsidiary company of JABIL (Fortune 200), which specializes in development, manufacturing and marketing of advanced medical devices. JABIL handles manufacturing of devices used in both home and hospital settings for hypertension detection through hemodynamic management. Design and manufacturing contract confirmed in March 2018.
• Tony Au & PartnersminorImplementation/ SI/ Consulting Partner · 1 November 2017Tony Au & Partners was selected as legal advisor for Sramek BioDynamics Hong Kong office in November 2017. Mr. Tony Au serves as Partner handling investment inquiries at Room 1808, 18th Floor, Tower One, Lippo Centre, 89 Queensway, Hong Kong.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Edwards Lifesciences: Now part of BD, Edwards Lifesciences is the dominant provider of hemodynamic monitoring solutions (Swan-Ganz catheters, FloTrac, ClearSight) for hospital critical-care settings. It is the most direct large-scale incumbent competing with Sramek BioDynamics' HOTMAN in hemodynamic and oxygen-transport monitoring.
• Baxter International: Baxter offers hemodynamic monitoring and patient monitoring solutions (e.g., Spectrum IQ, certain non-invasive platforms) as part of its broader hospital products portfolio. As a broad incumbent, it competes in the same hospital procurement decisions as Sramek BioDynamics.
• Philips Healthcare: Philips IntelliVue patient monitoring systems include hemodynamic and vital-signs modules commonly used in ICU/CCU environments. It is a broad incumbent competing for hospital hemodynamic monitoring budgets where HOTMAN would be evaluated.

Direct peers

• CNSystems: CNSystems produces the Task Force Monitor and CNAP continuous non-invasive arterial pressure and hemodynamic monitoring systems. It competes with HOTMAN in cardiology, hypertension work-up, and perioperative hemodynamics, sharing the same non-invasive positioning.
• USCOM: USCOM manufactures the USCOM 1A, a non-invasive suprasternal Doppler-based cardiac output monitor. It serves overlapping markets (emergency, critical care, cardiology) and represents a similar non-invasive hemodynamic positioning to Sramek's TEB-based HOTMAN.
• LiDCO Group (Masimo): LiDCO, now part of Masimo, provides non-invasive/minimally-invasive cardiac output monitoring (LiDCOunity, LiDCOrapid) used in ICU and OR. It is a direct competitor to Sramek BioDynamics on non-invasive continuous hemodynamic monitoring in the same hospital departments.
• Deltex Medical: Deltex Medical markets CardioQ, a non-invasive (esophageal Doppler) continuous cardiac output monitor used in surgical and ICU settings. It directly competes with HOTMAN on the same clinical use cases (hemodynamic optimization, fluid management, perioperative monitoring).
• ICU Medical (Cheetah Medical): Cheetah Medical (now an ICU Medical subsidiary) offers Starling SV, a non-invasive cardiac output monitor used in ICU and perioperative settings. Like Sramek BioDynamics' HOTMAN, it competes on non-invasive hemodynamic parameters and shares target clinical buyers (intensivists, anesthesiologists).

Emerging players

• Withings: Withings produces connected health devices (BPM Core, Sleep Analyzer, ScanWatch) integrated into a consumer health ecosystem similar to Cardiax's health-band/API model. It represents a consumer-electronics peer in the home cardiovascular and vital-signs monitoring space.
• AliveCor: AliveCor's KardiaMobile ECG device competes with Cardiax in the home cardiovascular monitoring segment, particularly for senior consumers and arrhythmia detection. It represents a more consumer-facing, scale-funded peer to Sramek BioDynamics' home offering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/sramek_biodyns
• Facebookm.facebook.com/sramekbiodynamics/?ref=bookmarks
• LinkedInlinkedin.com/company/sramek-biodynamcs-incorporation

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sramek BioDynamics